Feb 20, 2020

Increased intracellular cyclic di-AMP levels impair growth and virulence of Bacillus anthracis

Journal of Bacteriology
Jia HuXiulian Sun

Abstract

Cyclic di-AMP (c-di-AMP) is a recently identified bacterial second messenger that regulates biological processes. In this study, we found that inactivation of two c-di-AMP phosphodiesterases (PDEs), GdpP and PgpH, resulted in accumulation of 3.8 folds higher c-di-AMP levels than the parental strain Sterne in Bacillus anthracis and inhibited bacterial growth. Moreover, c-di-AMP accumulation decreased bacterial toxin expression, increased sensitivity to osmotic stress and detergent, and attenuated virulence in both C57BL/6J and A/J mice. Complementation of the PDE mutant with a plasmid carrying gdpP or pgpHin trans from a Pspac promoter restored bacterial growth, virulence factors expression, and resistant to detergent. Our results indicate that c-di-AMP is a pleiotropic signaling molecule in B. anthracis that is important for host-pathogen interaction.ImportanceAnthrax is an ancient and deadly disease caused by the spore-forming bacterial pathogen Bacillus anthracis. Vegetative cells of this species produce anthrax toxin proteins and S layer components during infection of mammalian hosts. So far, how the expression of these virulence factors is regulated remains largely unknown. Our results suggest that elevated c-di-AMP levels ...Continue Reading

  • References45
  • Citations

References

  • References45
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Promoter
Plasmids
Pde5a protein, mouse
Intracellular
Study
Stress
Anthrax toxin lethal factor
B6.129S7-Rag1-tm1Mom Mouse
Anthrax toxin
S-layer

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.